Last Posted: Jun 21, 2018
- Mendelian Randomization Evidence for Cardiovascular Precision Medicine
C O'Donnell, JAMA Cardiology, June 20, 2018 - Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies.
Köhler Cristiano A et al. Journal of psychiatric research 2018 May 189-207 - PCSK9 genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study
D Lyall et al, BioRxIV preprints, May 31, 2018 - Using genetic data to strengthen causal inference in observational research
JB Pingault et al, Nat Rev Genetics, June 5, 2018 - From genome-wide association studies to Mendelian randomization: Novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment.
Benn Marianne et al. Cardiovascular research 2018 Feb - HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
Vitali Cecilia et al. Current cardiology reports 2017 Nov 19(12) 132 - Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279?013 individuals.
Lauridsen Bo Kobberø et al. European heart journal 2017 Dec - Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279013 individuals
D Kobber et al, Eur Heart J, Dec 8, 2017 - Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
D Kobber et al, Eur Heart J, Dec 8, 2017 - The influence of big (clinical) data and genomics on precision medicine and drug development.
Denny Joshua C et al. Clinical pharmacology and therapeutics 2017 Nov
.png)
No hay comentarios:
Publicar un comentario